Over the last 20 years, the sequencing of the human genome, along with related organisms, has represented one of the largest scientific endeavours in the history of mankind. The information... — full story
A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for... — full story
University of Utah scientists developed a new kind of 'molecular condom' to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal... — full story
Bioinformatics researchers from UC San Diego just moved closer to unlocking the mystery of how human cells switch from 'proliferation mode' to 'specialisation mode.' This computational... — full story
Sticky is good. A University of California, San Diego bioengineer is the first author on an article in the journal Science that provides insights on the 'stickiness of life.' The big... — full story
Excess amounts of a naturally fluorescent molecule found in all living cells could serve as a natural biomarker for cancer, according to bioengineers. NADH, or nicotinamide adenine... — full story
Current treatments for diseases like cancer typically destroy nasty malignant cells, while also hammering the healthy ones. Using new advances in synthetic biology, researchers are... — full story
Engineers at the University of California at San Diego have come up with a way to help accelerate bone growth through the use of nanotubes and stem cells. This new finding could lead... — full story
'Astronaut food' malaria tests promise better diagnoses in developing worldResearchers at the University of Washington have developed a prototype malaria test printed on a disposable Mylar card that could easily slip into your wallet and still work when you... — full story
Rather than testing for individual marker genes or proteins, researchers at the University of California, San Diego (UC San Diego) and the Moores UCSD Cancer Centre have evidence that... — full story